Clinical Trial

Mpox Comprehensive Assessment for Responsive Immunisation in Emergency Outbreaks

Study acronym: MPOX CARE
Recruiting
View on ClinicalTrials.gov →
Summary
The MPXV CARE study principally aims to use clinical and epidemiology data to target specific individuals willing and able to provide appropriate and proportionate biological samples to develop novel immune diagnostics that support models of disease burden and future vaccine utilisation.
Trial Details
NCT Number NCT06887556
Lead Sponsor University of Birmingham
Collaborators: Rwanda Biomedical Centre
Conditions Mpox
Enrollment 650 participants
Start Date 2025-02-05
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-20